Melatonina Aurobindo (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, signaling darkness and promoting the physiological changes that initiate sleep. This receptor activation helps synchronize the internal clock with external light‑dark cycles, facilitating sleep onset and improving sleep quality.

The appropriate dose of Melatonina Aurobindo is determined by a qualified prescriber based on the individual’s age, condition, and response. Patients should follow the healthcare professional’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use in pregnancy and lactation are limited. Healthcare providers usually recommend avoiding routine use unless the potential benefit outweighs any possible risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician.

To request Melatonina Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike traditional hypnotics such as benzodiazepines, melatonin works by mimicking the body’s natural hormone rather than depressing central nervous system activity. This generally results in fewer next‑day residual effects, but efficacy may be lower for severe insomnia, where prescription hypnotics might be preferred.

Store Melatonina Aurobindo at ambient temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight, and extreme heat to maintain potency throughout its shelf life.

Melatonina Aurobindo is taken orally, typically with a glass of water. It is usually administered shortly before the desired bedtime, but the exact timing and frequency should follow the prescriber’s directions.

Serious but rare risks include severe allergic reactions (rash, swelling, anaphylaxis), worsening depression or emergence of suicidal thoughts, and, in very uncommon cases, seizures. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to melatonin or any excipients, patients taking interacting CNS depressants without medical supervision, and those with uncontrolled severe hepatic disease should avoid using Melatonina Aurobindo unless a physician advises otherwise.